 |
| Alexander "Bo" Cumbo |
Stanton PR & Marketing represents the syndicate of high-powered life sciences investors that created AavantiBio, a gene therapy company focused on patients with rare genetic disorders.
Bain Capital Life Sciences, Perceptive Advisors, RA Capital Management and Sarepta Therapeutics put together $107M in Series A financing to launch AavantiBio.
Alexander “Bo” Cumbo, who served as chief commercial officer and executive VP at Sarepta, will helm AavantiBio, which is headquartered in the Boston area.
“Bo Cumbo has built a first-in-class rare disease commercial organization and has made tremendous contributions to Sarepta," said Doug Ingram, CEO. “We look forward to continuing to work with Bo as he builds a strong AavantiBio team and advances therapies to treat FA and other rare diseases.”
Stanton’s Scott Lessne handles AavantiBio.
Amsterdam’s CFF Communications handles Accell Group as Europe’s No 1 e-bike and No. 2 bicycle maker declares insolvency after failing to find a buyer.
Randy Sinclair, who rose to lead investor relations at Chevron during an 11-year run, will move to Northrop Grumman on Aug. 10 as VP-IR.
Trailrunner International is handling Axum Capital Partners’ move to acquire a controlling interest in BARCODE, a performance hydration brand, in partnership with NBA All-Star Victor Wembanyama.
Alpha IR and Alpha Advisory Group represent McKinley Acquisition Corp. as it plans to take hostile drone spotter and destroyer Space-Eyes public via a SPAC deal valued at $370M.
FGS Global keeps its position at the top of the heap in Mergermarket’s rankings of the top PR advisors in M&A deals for 1H26.
